Position in ABBV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$106,855,881
+$43,934,077 QoQ
Shares Held
491,314
+78.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 35.415844042709956.ToString("F0")%
Shared 0.ToString("F0")%
None 64.58415595729005.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PANAGORA ASSET MANAGEMENT INC holds $1,061,603,698 across 9 Drug Manufacturers - General names. ABBV ranks #5 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
322,677 | $296,788,624 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,715,745 | $225,359,934 | |
| 3 | JNJ |
Johnson & Johnson
|
777,778 | $190,120,054 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,165,376 | $162,418,453 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
491,314 | $106,855,881 | |
| 6 | AMGN |
Amgen Inc
|
96,119 | $33,819,470 | |
| 7 | BIIB |
Biogen Inc.
|
142,065 | $26,044,776 | |
| 8 | MRK |
Merck & Co., Inc.
|
147,569 | $17,751,075 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,855,881 | 491,314 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $62,921,804 | 275,381 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $38,272,172 | 165,294 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $25,025,659 | 134,822 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $46,450,374 | 221,699 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $113,028,572 | 636,064 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $147,764,804 | 748,252 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $75,492,126 | 440,136 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $150,600,159 | 827,019 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $128,756,204 | 830,846 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $98,309,839 | 659,532 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $91,670,426 | 680,401 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $115,614,010 | 725,444 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $111,137,580 | 687,690 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $86,869,972 | 647,269 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $94,482,566 | 616,888 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $83,829,188 | 517,113 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $105,122,529 | 776,385 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $81,493,088 | 755,475 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $75,462,604 | 669,945 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $75,691,773 | 699,425 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,759,848 | 53,755 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $81,341,767 | 928,665 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $111,013,500 | 1,130,714 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $90,831,813 | 1,192,175 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||